NO20053090D0 - Powder formulation for inhalation containing tiotropium. - Google Patents

Powder formulation for inhalation containing tiotropium.

Info

Publication number: NO20053090D0
Authority: NO; Norway
Prior art keywords: powder formulation; containing tiotropium; inhalation containing; inhalation; tiotropium
Prior art date: 2002-11-28

Application number

NO20053090A

Other languages

Norwegian (no)

Other versions

NO20053090L (en

Inventor

Michael Walz

Michael Trunk

Mareke Hartig-Heimel

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-28

Filing date

2005-06-23

Publication date

2005-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053090(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-23 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-06-23 Publication of NO20053090L publication Critical patent/NO20053090L/en

2005-06-23 Publication of NO20053090D0 publication Critical patent/NO20053090D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
- A61M15/0026—Hinged caps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20053090A 2002-11-28 2005-06-23 Powder formulation for inhalation containing tiotropium. NO20053090D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10255387A DE10255387A1 (en)	2002-11-28	2002-11-28	New tiotropium-containing powder formulation for inhalation
PCT/EP2003/012911 WO2004047796A2 (en)	2002-11-28	2003-11-19	Pulverulent formulation for inhalation containing tiotropium

Publications (2)

Publication Number	Publication Date
NO20053090L NO20053090L (en)	2005-06-23
NO20053090D0 true NO20053090D0 (en)	2005-06-23

Family

ID=32308760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053090A NO20053090D0 (en)	2002-11-28	2005-06-23	Powder formulation for inhalation containing tiotropium.

Country Status (33)

Country	Link
EP (1)	EP1567135B1 (en)
JP (1)	JP4977321B2 (en)
KR (1)	KR101066805B1 (en)
CN (1)	CN100574751C (en)
AR (1)	AR042242A1 (en)
AT (1)	ATE401861T1 (en)
AU (1)	AU2003294714B2 (en)
BR (1)	BR0316343A (en)
CA (1)	CA2507579C (en)
CO (1)	CO5580736A2 (en)
CY (1)	CY1108420T1 (en)
DE (2)	DE10255387A1 (en)
DK (1)	DK1567135T3 (en)
EA (1)	EA011549B1 (en)
EC (1)	ECSP055821A (en)
ES (1)	ES2310681T3 (en)
HR (1)	HRP20050468A2 (en)
IL (1)	IL168810A (en)
ME (1)	MEP51608A (en)
MX (1)	MXPA05005485A (en)
MY (1)	MY140890A (en)
NO (1)	NO20053090D0 (en)
PE (1)	PE20040848A1 (en)
PL (1)	PL376229A1 (en)
PT (1)	PT1567135E (en)
RS (1)	RS20050400A (en)
SA (1)	SA04240467B1 (en)
SI (1)	SI1567135T1 (en)
TW (1)	TWI332837B (en)
UA (1)	UA81930C2 (en)
UY (1)	UY28096A1 (en)
WO (1)	WO2004047796A2 (en)
ZA (1)	ZA200502859B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006016904A1 (en) *	2006-04-11	2007-10-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	inhaler
DE102008014025A1 (en) *	2008-03-13	2009-09-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhaler and strainer for an inhaler
TR200909788A2 (en)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Dry powder formulation suitable for inhalation with tiotropium
PE20171256A1 (en) *	2010-08-03	2017-08-28	Chiesi Farm Spa	DRY POWDER FORMULATION INCLUDING A PHOSPHODIESTERASE INHIBITOR
BR112015010601B1 (en) *	2012-11-09	2022-07-19	Civitas Therapeutics, Inc.	PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
KR101748796B1 (en) *	2015-09-30	2017-06-19	한미약품 주식회사	Inhalation capsule with enhanced delivery rate of active ingredients
KR101728116B1 (en) *	2015-11-03	2017-04-18	한미약품 주식회사	Dry powder composition for inhalation comprising tiotropium or pharmaceutically acceptable salt thereof
CN111514418B (en) *	2019-06-12	2022-01-14	中南大学湘雅二医院	Self-suction nasal powder material feeding device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1242211A (en) *	1967-08-08	1971-08-11	Fisons Pharmaceuticals Ltd	Pharmaceutical composition
US3957965A (en) *	1967-08-08	1976-05-18	Fisons Limited	Sodium chromoglycate inhalation medicament
DE4140689B4 (en) *	1991-12-10	2007-11-22	Boehringer Ingelheim Kg	Inhalable powders and process for their preparation
DE4318455A1 (en) *	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Capsule holder
GB9322014D0 (en) *	1993-10-26	1993-12-15	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (en) *	1994-07-16	1996-01-18	Asta Medica Ag	Formulation for inhalation application
ES2192866T3 (en) *	1998-11-13	2003-10-16	Jago Res Ag	DRY POWDER FOR INHALATION.
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
MXPA02005666A (en) *	2000-10-12	2002-11-29	Boehringer Ingelheim Pharma	Novel tiotropium-containing inhalation powder.
UA75375C2 (en) *	2000-10-12	2006-04-17	Boehringer Ingelheim Pharma	Method for producing powdery preparations for inhaling
DE10126924A1 (en) *	2001-06-01	2002-12-05	Boehringer Ingelheim Pharma	Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10141377A1 (en) *	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Scattering process for the production of powder formulations
PL207752B1 (en) *	2002-04-04	2011-01-31	Boehringer Ingelheim Pharma	Powder formulations suitable for inhalation
UA80123C2 (en) *	2002-04-09	2007-08-27	Boehringer Ingelheim Pharma	Inhalation kit comprising inhalable powder of tiotropium

2002
- 2002-11-28 DE DE10255387A patent/DE10255387A1/en not_active Withdrawn
2003
- 2003-11-19 UA UAA200506224A patent/UA81930C2/en unknown
- 2003-11-19 WO PCT/EP2003/012911 patent/WO2004047796A2/en not_active Ceased
- 2003-11-19 EA EA200500864A patent/EA011549B1/en not_active IP Right Cessation
- 2003-11-19 ES ES03785648T patent/ES2310681T3/en not_active Expired - Lifetime
- 2003-11-19 KR KR1020057009548A patent/KR101066805B1/en not_active Expired - Lifetime
- 2003-11-19 JP JP2004554384A patent/JP4977321B2/en not_active Expired - Lifetime
- 2003-11-19 HR HR20050468A patent/HRP20050468A2/en not_active Application Discontinuation
- 2003-11-19 PT PT03785648T patent/PT1567135E/en unknown
- 2003-11-19 DE DE50310208T patent/DE50310208D1/en not_active Expired - Lifetime
- 2003-11-19 MX MXPA05005485A patent/MXPA05005485A/en active IP Right Grant
- 2003-11-19 PL PL03376229A patent/PL376229A1/en unknown
- 2003-11-19 EP EP03785648A patent/EP1567135B1/en not_active Revoked
- 2003-11-19 RS YUP-2005/0400A patent/RS20050400A/en unknown
- 2003-11-19 AU AU2003294714A patent/AU2003294714B2/en not_active Expired
- 2003-11-19 AT AT03785648T patent/ATE401861T1/en active
- 2003-11-19 DK DK03785648T patent/DK1567135T3/en active
- 2003-11-19 CN CN200380104599A patent/CN100574751C/en not_active Expired - Lifetime
- 2003-11-19 CA CA2507579A patent/CA2507579C/en not_active Expired - Fee Related
- 2003-11-19 SI SI200331323T patent/SI1567135T1/en unknown
- 2003-11-19 ME MEP-516/08A patent/MEP51608A/en unknown
- 2003-11-19 BR BR0316343-1A patent/BR0316343A/en not_active Application Discontinuation
- 2003-11-26 TW TW092133185A patent/TWI332837B/en not_active IP Right Cessation
- 2003-11-26 UY UY28096A patent/UY28096A1/en not_active Application Discontinuation
- 2003-11-26 PE PE2003001200A patent/PE20040848A1/en not_active Application Discontinuation
- 2003-11-27 MY MYPI20034544A patent/MY140890A/en unknown
- 2003-11-28 AR ARP030104393A patent/AR042242A1/en unknown
2004
- 2004-01-03 SA SA04240467A patent/SA04240467B1/en unknown
2005
- 2005-04-08 ZA ZA200502859A patent/ZA200502859B/en unknown
- 2005-05-26 IL IL168810A patent/IL168810A/en not_active IP Right Cessation
- 2005-05-26 EC EC2005005821A patent/ECSP055821A/en unknown
- 2005-06-23 NO NO20053090A patent/NO20053090D0/en not_active Application Discontinuation
- 2005-06-27 CO CO05062904A patent/CO5580736A2/en not_active Application Discontinuation
2008
- 2008-10-16 CY CY20081101149T patent/CY1108420T1/en unknown

Also Published As

Publication number	Publication date
PE20040848A1 (en)	2005-01-14
SI1567135T1 (en)	2008-10-31
AR042242A1 (en)	2005-06-15
CN1717225A (en)	2006-01-04
PL376229A1 (en)	2005-12-27
KR20050086887A (en)	2005-08-30
JP2006510622A (en)	2006-03-30
PT1567135E (en)	2008-09-01
NO20053090L (en)	2005-06-23
MY140890A (en)	2010-01-29
EA011549B1 (en)	2009-04-28
CO5580736A2 (en)	2005-11-30
KR101066805B1 (en)	2011-09-22
UY28096A1 (en)	2004-06-30
DE50310208D1 (en)	2008-09-04
ES2310681T3 (en)	2009-01-16
DE10255387A1 (en)	2004-06-09
IL168810A (en)	2015-02-26
HRP20050468A2 (en)	2006-07-31
EP1567135A2 (en)	2005-08-31
SA04240467B1 (en)	2008-10-15
ZA200502859B (en)	2006-02-22
DK1567135T3 (en)	2008-10-27
RS20050400A (en)	2007-04-10
BR0316343A (en)	2005-09-27
ECSP055821A (en)	2005-08-11
TW200500066A (en)	2005-01-01
CN100574751C (en)	2009-12-30
UA81930C2 (en)	2008-02-25
HK1085918A1 (en)	2006-09-08
JP4977321B2 (en)	2012-07-18
CA2507579C (en)	2011-07-19
AU2003294714A1 (en)	2004-06-18
MXPA05005485A (en)	2005-07-25
EA200500864A1 (en)	2006-02-24
MEP51608A (en)	2011-02-10
WO2004047796A3 (en)	2004-09-30
AU2003294714B2 (en)	2009-10-08
ATE401861T1 (en)	2008-08-15
TWI332837B (en)	2010-11-11
WO2004047796A2 (en)	2004-06-10
EP1567135B1 (en)	2008-07-23
CA2507579A1 (en)	2004-06-10
CY1108420T1 (en)	2014-04-09

Publication	Publication Date	Title
SI1496858T1 (en)	2013-12-31	An inhalation kit comprising an inhalable powder, tiotropium
DK1658872T4 (en)	2019-11-11	POWDER INHALER
DK1670472T3 (en)	2008-04-21	Aerosol formulation for inhalation containing an anticholinergic
EG25378A (en)	2011-12-22	Powder inhalator.
DK1615646T4 (en)	2022-10-10	PHARMACEUTICAL FORMULATIONS CONTAINING METHYLNALTREXONE
EE200200428A (en)	2003-02-17	Innovative inhalation powder containing tiotropium
IL179757A0 (en)	2007-05-15	Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
AU300689S (en)	2005-02-15	Powder inhalator
IL178689A0 (en)	2007-02-11	Pharmaceutical solution formulations containing 17-aag
ZA200503546B (en)	2006-10-25	Tiotropium containing HFC solution formulations
IL175127A0 (en)	2006-09-05	Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
AU2003294927A1 (en)	2004-08-10	Powder inhalator
AU2003267809A8 (en)	2003-12-22	Powder inhaler
DE602004022810D1 (en)	2009-10-08	MORE DOSE INHALER
DK1496876T3 (en)	2008-06-02	Aerosol formulation for inhalation containing tiotropium bromide
NO20053090D0 (en)	2005-06-23	Powder formulation for inhalation containing tiotropium.
DK1173244T3 (en)	2005-02-28	Powder inhaler for combined drug
ITMI20031342A1 (en)	2005-01-02	INHALATION DEVICE FOR AEROSOL.
PL371356A1 (en)	2006-05-29	New compounds, sulphorafan analogues and the pharmaceutical compound

Legal Events

Date	Code	Title	Description
2015-11-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application